KC expression of IFN-κ is induced by CRISPR/Cas9 transfection, and IFN-κ directly affects the expression of APOBEC3 cytidine deaminases that in turn promote degradation of intracellular CRISPR/Cas9 plasmids. The gene discussed is IFNK; the disease is keratoconus.